Sort by
Items per page

Send to

Choose Destination

Best matches for OXYCODONE/PD:

Search results

Items: 1 to 20 of 1343


Oxycodone/naloxone in postoperative pain management of surgical patients.

Gkegkes ID, Minis EE, Iavazzo C.

J Opioid Manag. 2018 Jan/Feb;14(1):52-60. doi: 10.5055/jom.2018.0429. Review.


A prospective, randomized, open label, controlled study investigating the efficiency and safety of 3 different methods of rectus sheath block analgesia following midline laparotomy.

Purdy M, Kinnunen M, Kokki M, Anttila M, Eskelinen M, Hautajärvi H, Lehtonen M, Kokki H.

Medicine (Baltimore). 2018 Feb;97(7):e9968. doi: 10.1097/MD.0000000000009968.


Effect of oxycodone hydrochloride combined with flurbiprofen axetil for intravenous patient-controlled analgesia in lower abdominal patients: A randomized trial.

Xiang X, Yuan X, Lian Y, Fang J, Wu Y.

Medicine (Baltimore). 2018 Feb;97(7):e9911. doi: 10.1097/MD.0000000000009911.


Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users.

Setnik B, Schoedel K, Bartlett C, Dick C, Hakim N, Geoffroy P.

J Opioid Manag. 2017 Nov/Dec;13(6):449-464. doi: 10.5055/jom.2017.0421.


Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder.

Cassidy TA, Thorley E, Black RA, DeVeaugh-Geiss A, Butler SF, Coplan P.

J Opioid Manag. 2017 Nov/Dec;13(6):425-440. doi: 10.5055/jom.2017.0419.


Oxycodone Ingestion Patterns in Acute Fracture Pain With Digital Pills.

Chai PR, Carreiro S, Innes BJ, Chapman B, Schreiber KL, Edwards RR, Carrico AW, Boyer EW.

Anesth Analg. 2017 Dec;125(6):2105-2112. doi: 10.1213/ANE.0000000000002574.


Effect of a Single Dose of Oral Opioid and Nonopioid Analgesics on Acute Extremity Pain in the Emergency Department: A Randomized Clinical Trial.

Chang AK, Bijur PE, Esses D, Barnaby DP, Baer J.

JAMA. 2017 Nov 7;318(17):1661-1667. doi: 10.1001/jama.2017.16190.


Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain.

Kim ES.

Clin Drug Investig. 2017 Dec;37(12):1191-1201. doi: 10.1007/s40261-017-0593-1. Review.


Oxycodone Resistance Due to Rifampin Use in an Osteosarcoma Patient with Tuberculosis.

Sakamoto A, Yamashita M, Hori Y, Okamoto T, Shimizu A, Matsuda S.

Am J Case Rep. 2017 Oct 24;18:1130-1134.


Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350.

Poulsen JL, Brock C, Grønlund D, Liao D, Gregersen H, Krogh K, Drewes AM.

Dig Dis Sci. 2017 Nov;62(11):3156-3166. doi: 10.1007/s10620-017-4784-7. Epub 2017 Oct 6.


Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).

Matsuoka H, Tsurutani J, Chiba Y, Fujita Y, Terashima M, Yoshida T, Sakai K, Otake Y, Koyama A, Nishio K, Nakagawa K.

BMC Cancer. 2017 Oct 6;17(1):674. doi: 10.1186/s12885-017-3664-z.


Transumbilical versus lateral transabdominal removal of benign adnexal masses in laparoscopic surgery-A randomized trial.

Kilpiö O, Härkki PSM, Mentula MJ, Jokela RM, Pakarinen PI.

Eur J Obstet Gynecol Reprod Biol. 2017 Nov;218:49-54. doi: 10.1016/j.ejogrb.2017.08.040. Epub 2017 Sep 4.


In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations.

Mayock SP, Saim S, Fleming AB.

Clin Drug Investig. 2017 Dec;37(12):1117-1124. doi: 10.1007/s40261-017-0561-9. Erratum in: Clin Drug Investig. 2017 Dec;37(12 ):1203.


Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects, in comparison to an established twice-daily tablet

Scheidel B, Maritz MA, Gschwind YJ, Steigerwald K, Guth V, Kovacs P, Rey H.

Int J Clin Pharmacol Ther. 2017 Nov;55(11):881-890. doi: 10.5414/CP203005.


Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment.

Toyama K, Kiyosawa N, Watanabe K, Ishizuka H.

Int J Mol Sci. 2017 Sep 16;18(9). pii: E1991. doi: 10.3390/ijms18091991.


Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial.

Lee KH, Kim TW, Kang JH, Kim JS, Ahn JS, Kim SY, Yun HJ, Eum YJ, Koh SA, Kim MK, Hong YS, Kim JE, Lee GW.

Chin J Cancer. 2017 Sep 11;36(1):74. doi: 10.1186/s40880-017-0241-4.


The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats.

You ZB, Gao JT, Bi GH, He Y, Boateng C, Cao J, Gardner EL, Newman AH, Xi ZX.

Neuropharmacology. 2017 Nov;126:190-199. doi: 10.1016/j.neuropharm.2017.09.007. Epub 2017 Sep 6.


Choice between delayed food and immediate opioids in rats: treatment effects and individual differences.

Panlilio LV, Secci ME, Schindler CW, Bradberry CW.

Psychopharmacology (Berl). 2017 Nov;234(22):3361-3373. doi: 10.1007/s00213-017-4726-2. Epub 2017 Sep 4.


A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.

Nosek K, Leppert W, Nosek H, Wordliczek J, Onichimowski D.

Drug Des Devel Ther. 2017 Aug 22;11:2409-2419. doi: 10.2147/DDDT.S141007. eCollection 2017.


Spasmolytic Mechanism of Aqueous Licorice Extract on Oxytocin-Induced Uterine Contraction through Inhibiting the Phosphorylation of Heat Shock Protein 27.

Yang L, Chai CZ, Yan Y, Duan YD, Henz A, Zhang BL, Backlund A, Yu BY.

Molecules. 2017 Aug 29;22(9). pii: E1392. doi: 10.3390/molecules22091392.

Supplemental Content

Loading ...
Support Center